Hodgkin lymphoma in Pakistan: An analysis of subtypes and their correlation with epstein barr virus

Asian Pacific Journal of Cancer Prevention

Volumn 12, Issue 6, 2011, Pages 1385-1388

  Fatima, Samia ^a   Ahmed, Rashida ^a   Ahmed, Arsalan ^a  

^a AGA KHAN UNIVERSITY HOSPITAL   (Pakistan)

Author keywords

Epstein Barr virus; Hodgkin lymphoma; Latent membrane protein 1 (LMP 1)

Indexed keywords

EID: 84858009876     PISSN: 15137368     EISSN: 2476762X     Source Type: Journal    
DOI: None     Document Type: Article

References (18)

1. Akram M, Cheema MH, Sana S, et al (2001). Hodgkin's Disease: Analysis of 75 patients. J Coll Physicians Surg Pak, 11, 702-5.
2. Chang KC, Khen NT, Jones D, et al (2005). Epstein-Barr virus is associated with all histological subtypes of Hodgkin lymphoma in Vietnamese children with special emphasis on the entity of lymphocyte predominance subtype. Hum Pathol, 36, 747-55.
3. Claviez A, Tiemann M, Luders H, et al (2005). Impact of latent Epstein-Barr virus infection on outcome in children and adolescents with Hodgkin's Lymphoma. J Clin Oncol, 23, 4048-56.
4. Dinand V, Arya LS. (2006). Epidemiology of childhood Hodgkin's disease: Is it different in developing countries?. Indian Pediatrics, 43, 141-5.
5. Jaffe ES, Harris NL, Stein H, et al (2001). Tumors of hematopoietic and lymphoid tissues. Pathology and Genetics, World Health Organization Classification of tumors, IARC Press, Lyon.
6. Jarrett RF, Stark GL, White J, et al (2003). Impact of tumor Epstein-Barr virus status on presenting features and outcome in age-defined subgroups of patients with classic Hodgkin lymphoma: a population-based study. Blood, 106, 2444-51.
7. Karnik S, Srinavasan B, Nair S (2003). Hodgkin's lymphoma: immunohistochemical features and association with EBV LMP-1 from a South Indian Hospital. Pathology, 35, 207-11.
8. Khan G, Norton AJ, Slavin G, (1993). Epstein Barr virus in Hodgkin's disease: Relation to age and subtype. Cancer, 71, 3124-9.
9. Khan HI, Abdullah A, Saerun Nisa, (2005). Pattern of Hodgkin's lymphoma in children. Pakistan Ped J, 29,145-9.
10. Kumar V, Abbas AK, Fausto N, (2004) Pathologic Basis of Disease. 9th ed Elsevier Philadelphia (Pennsylvania) p. 686-90.
11. Lukes RJ, Craver LF, Hall TC, et al (1996). Report of Nomenclature Committee. Cancer Res, 16, 1311.
12. Makar RR, Saji T, Junaid TA. (2003) Epstein-Barr virus expression in Hodgkin's lymphoma in Kuwait. Pathol Oncol Res, 9, 159-65.
13. Matteo ED, Baron AV, Chabay P, et al (2003). Comparison of Epstein Barr virus presence in Hodgkin's lymphoma in pediatric versus adult Argentine patients. Arch Pathol Lab Med, 127, 1325-9.
14. Morente MM, Piris MA, Abraira V (1997). Adverse clinical outcome in Hodgkin's disease is associated with loss of retinoblastoma protein expression, high Ki67 proliferation index, and absence of Epstein-Barr virus-latent membrane protein 1 expression. Blood, 90, 2429-36.
15. Murray PG, Billingham LI, Hassan TH, et al (1999). Effect of Epstein -Barr virus infection on response to chemotherapy and survival in Hodgkin's disease. Blood, 94, 442-7.
16. Naresh KN, Johnson J, Srinivas V, et al (2000). Epstein-Barr virus association in classical Hodgkin's disease provides survival advantage to patients and correlates with higher expression of proliferation markers in Reed-Sternberg cells. Annals Oncol, 11, 91-6.
17. Rosai J. Rosai and Ackerman's Surgical Pathology.9thed. (2004) Elsevier St.Louise (MO): p.1917-3.
18. Zhou XG, Sandvej K, Li PJ, et al (2001). Epstein-Barr virus (EBV) in Chinese pediatric Hodgkin disease: Hodgkin disease in young children is an EBV-related lymphoma. Cancer, 15, 1621-31.